Filing metadata

Accession number
0001415889-21-004815
Form type
Form 3
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Oct 08, 2021
Reporting period
Sep 30, 2021
Description
Initial ownership

Explore SEC Filings Hub